Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart
Clinical trial NCT01359618 · TERMINATED
Trial details
- NCT number
- NCT01359618
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.